Effect of Thick-Needle Therapy in Patients with Bell's Palsy at Recovery Stage: A Multi-center Randomized Controlled Trial

被引:0
|
作者
YU Bin-yan [1 ]
WANG Yan-ping [2 ]
SHANG Hong-cai [3 ]
WANG Li-ying [2 ]
WAN Yi-jia [1 ]
ZHAO Chen [4 ]
XUAN Li-hua [1 ]
机构
[1] Department of Acupuncture and Moxibustion, The First Affiliated Hospital of Zhejiang Chinese Medical University
[2] Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
[3] Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital
[4] The Graduate School,Tianjin University of Traditional Chinese Medicine
关键词
Bell’s palsy; acupuncture; thick-needle therapy; randomized controlled trial; Chinese medicine;
D O I
暂无
中图分类号
R745.12 [];
学科分类号
1002 ;
摘要
Objective: To compare the clinical effects of thick-needle therapy(TNT) and acupuncture therapy(AT) on patients with Bell’s palsy(BP) at the recovery stage. Methods: A total of 146 eligible participants from 3 hospitals in China were randomized into the TNT group(73 cases) and the AT group(73 cases) using a central randomization. Both groups received Western medicine thrice a day for 4 weeks. Moreover, patients in the TNT group received subcutaneous insertion of a thick needle into Shendao(GV 11) acupoint, while patients in the AT group received AT at acupoints of Cuanzhu(BL 2), Yangbai(GB 14), Dicang(ST 4), Xiaguan(ST 7), Jiache(ST 6), Yingxiang(LI 20) and Hegu(LI 4), 4 times a week, for 4 weeks. Both groups received 2 follow-up visits, which were arranged at 1 month and 3 months after treatment, respectively. The primary outcome measure was House-Brackmann Facial Nerve Grading System(HBFNGS) grade. And the clinical recovery rates of both groups were evaluated according to the HBFNGS grades after treatment. The secondary outcome measures included the facial disability index(FDI) and electroneurogram(Eno G). The adverse events were observed and recorded in both groups. Results: Three cases withdrew from the trial, 2 in the TNT group and 1 in the AT group. There was no significant difference in the clinical recovery rates between the TNT and AT groups after 4-week treatment [40.85%(29/71) vs. 34.72%(25/72), P>0.05]. At the 2 nd follow-up visit, more patients in the TNT group showed reduced HBFNGS grades than those in the AT group(P<0.01). No significant difference was observed between the two groups in FDI score, EnoG latency and maximum amplitude ratio at all time points(all P>0.05). Conclusion: The clinical effect of TNT was equivalent to that of AT in patients with BP at recovery stage, while the post-treatment effect of TNT was superior to that of AT.(Registration No. Chi CTR-INR-16008409)
引用
收藏
页码:455 / 461
页数:7
相关论文
共 50 条
  • [41] Oxymatrine therapy for chronic hepatitis B:A randomized doubleblind and placebo-controlled multi-center trial
    Lun-Gen Lu Min-De Zeng Yi-Min Mao Ji-Qiang Li
    World Journal of Gastroenterology, 2003, 9 (11) : 2480 - 2483
  • [42] Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial
    Teodora Radonic
    Piet de Witte
    Marieke JH Baars
    Aeilko H Zwinderman
    Barbara JM Mulder
    Maarten Groenink
    Trials, 11
  • [43] Gatekeeper therapy: An endoscopic treatment for GERD: Randomized, sham-controlled multi-center trial overview
    Fockens, P
    Lei, A
    Edmundowicz, S
    Lehmkuhl, M
    Cohen, L
    D'Souza, C
    Rothstein, R
    Moriarty, C
    Nickl, N
    Nicholson, S
    Overholt, BF
    Miller, J
    Smith, CD
    Swafford, V
    Binmoeller, K
    Hauptman, D
    Vakil, N
    Dalmar, A
    Kahrilas, PJ
    Ebert, C
    Lee, T
    Hieston, K
    Lehman, GA
    GASTROINTESTINAL ENDOSCOPY, 2005, 61 (05) : AB136 - AB136
  • [44] Home-Based Group Education On Renal Replacement Therapy For Patients With End-Stage Renal Disease: A Multi-Center Randomized Controlled Trial.
    Massey, E.
    Gregoor, P. Smak
    Nette, R.
    van den Dorpel, M.
    van Kooij, A.
    Betjes, M.
    Zietse, R.
    Zuidema, W.
    Timman, R.
    Busschbach, J.
    Weimar, W.
    TRANSPLANTATION, 2014, 98 : 488 - 488
  • [45] Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial
    Jeon, Kyeongman
    Suh, Jae Kyung
    Jang, Eun Jin
    Cho, Songhee
    Ryu, Ho Geol
    Na, Sungwon
    Hong, Sang-Bum
    Lee, Hyun Joo
    Kim, Jae Yeol
    Lee, Sang-Min
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (14)
  • [46] Erratum to: Prednisolone and acupuncture in Bell’s palsy: study protocol for a randomized, controlled trial
    Feng Xia
    Junliang Han
    Xuedong Liu
    Jingcun Wang
    Zhao Jiang
    Kangjun Wang
    Songdi Wu
    Gang Zhao
    Trials, 15
  • [47] Reverse Hybrid Therapy Verse Standard Triple Therapy for Helicobacter pylori Infection - A Multi-Center, Randomized, Controlled Trial
    Hsu, Ping-I
    Wu, Deng-Chyang
    GASTROENTEROLOGY, 2014, 146 (05) : S740 - S740
  • [48] Quality assurance of HIV prevention counseling in a multi-center randomized controlled trial
    Kamb, ML
    Dillon, BA
    Fishbein, M
    Willis, KL
    PUBLIC HEALTH REPORTS, 1996, 111 : 99 - 107
  • [49] Efficacy of Digital Therapeutics for Pulmonary Rehabilitation: A Multi-Center, Randomized Controlled Trial
    Kim, Chul
    Choi, Hee-Eun
    Rhee, Chin Kook
    Song, Jun Hyeong
    Lee, Jae Ha
    LIFE-BASEL, 2024, 14 (04):
  • [50] Family Access to a Dentist Study (FADS): A multi-center randomized controlled trial
    Nelson, Suchitra
    Riedy, Christine
    Albert, Jeffrey M.
    Lee, Wonik
    Slusar, Mary Beth
    Curtan, Shelley
    Ferretti, Gerald
    Cunha-Cruz, Joana
    Milgrom, Peter
    CONTEMPORARY CLINICAL TRIALS, 2015, 45 : 177 - 183